Luke A. Probst

Andexanet alfa effectiveness and safety versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage while on apixaban or rivaroxaban: A single-center, retrospective, matched cohort analysis

Katie A Parsels, Robert W. Seabury, Stephanie Zyck et al. · The American Journal of Emergency Medicine · 2022 · 32 citations

Medicine, Hematology, Pharmacotherapy +17

Mixing and compatibility guide for commonly used aerosolized medications

David K. Burchett, William Darko, James Zahra et al. · American Journal of Health-System Pharmacy · 2010 · 21 citations

Pharmacy, Clinical Pharmacy, Pharmacy Practice +13

Inappropriate Vancomycin Therapeutic Drug Monitoring in Hospitalized Pediatric Patients Increases Pediatric Trauma and Hospital Costs

Manika Suryadevara, Kelly E. Steidl, Luke A. Probst et al. · The Journal of Pediatric Pharmacology and Therapeutics · 2012 · 21 citations · Full text

Pharmacy, Pediatric Pharmacy, Pediatrics +14

Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program

Pegah Shakeraneh, Tasaduq Fazili, Dongliang Wang et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2020 · 20 citations

Pharmacy, Clinical Pharmacy, Pharmacotherapy +13

Intravenous Clonidine Use in a Neonate Experiencing Opioid-induced Myoclonus

Brenda C. McClain, Luke A. Probst, Emese Pinter et al. · Anesthesiology · 2001 · 18 citations · Full text

Medicine, Pediatrics, Pharmacology +12